logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9889233 B1

PDFFull Text
Date of Patent:
Feb. 13, 2018

Filed:

Nov. 12, 2015

Method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair

Applicant:

Lars Lidgren, Lund, SE;

Inventor:

Lars Lidgren, Lund, SE;

Assignee:

ORTHOCELL LIMITED, Murdoc WA, AU;

Attorney:

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Primary Examiner:

Elizabeth C Kemmerer

Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); A61K 38/00 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61L 27/54 (2006.01); A61K 38/30 (2006.01); A61K 38/39 (2006.01); A61L 15/18 (2006.01); A61L 27/36 (2006.01); A61K 9/00 (2006.01); C12N 5/077 (2010.01);
U.S. Cl.
CPC ...
A61L 27/54 (2013.01); A61K 9/0019 (2013.01); A61K 38/1841 (2013.01); A61K 38/30 (2013.01); A61K 38/39 (2013.01); A61L 15/18 (2013.01); A61L 27/3604 (2013.01); A61L 27/3633 (2013.01); C12N 5/0655 (2013.01); A61L 2300/252 (2013.01); A61L 2300/414 (2013.01); A61L 2300/43 (2013.01); A61L 2400/06 (2013.01); A61L 2430/02 (2013.01); A61L 2430/10 (2013.01); A61L 2430/20 (2013.01); A61L 2430/24 (2013.01); A61L 2430/30 (2013.01); A61L 2430/32 (2013.01); A61L 2430/34 (2013.01); A61L 2430/38 (2013.01);
Abstract

A medical composition is disclosed, which is injectable and which comprises a mixture of native components, which are obtainable by culturing one or more cell samples from a human or animal during normal conditions, said native components being included in the group consisting of growth factors, extracellular matrix proteins, and other substances produced by said cell samples during normal conditions, and a pharmaceutically acceptable carrier, as well as a method for producing the native components, a method for producing the medical composition, a method for treating a subject in need of tissue repair by injection of the medical composition, and use of said mixture of native components for the production of said medical composition for tissue repair via injection. A medical composition is disclosed, which is injectable and which comprises a mixture of native components, which are obtainable by culturing one or more cell samples from a human or animal during normal conditions, said native components being included in the group consisting of growth factors, extracellular matrix proteins, and other substances produced by said cell samples during normal conditions, and a pharmaceutically acceptable carrier, as well as a method for producing the native components, a method for producing the medical composition, a method for treating a subject in need of tissue repair by injection of the medical composition, and use of said mixture of native components for the production of said medical composition for tissue repair via injection.

Find Patent Forward Citations

Loading…